Directional diffusivity as a magnetic resonance (MR) biomarker in demyelinating disease

Tammie L. S. Benzinger; Anne H. Cross M.D.; Junqian Xu; Robert Naismith; Shu-Wei Sun; Sheng-Kwei Song

doi:10.1117/12.740133

5 October 2007 Directional diffusivity as a magnetic resonance (MR) biomarker in demyelinating disease

Tammie L. S. Benzinger, Anne H. Cross M.D., Junqian Xu, Robert Naismith, Shu-Wei Sun, Sheng-Kwei Song

Proceedings Volume 6759, Smart Biomedical and Physiological Sensor Technology V; 67590O (2007) https://doi.org/10.1117/12.740133
Event: Optics East, 2007, Boston, MA, United States

Abstract

Directional diffusivities derived from diffusion tensor magnetic resonance imaging (DTI) measurements describe water movement parallel to (λ_||, axial diffusivity) and perpendicular to (λ⊥radial diffusivity) axonal tracts. λ_|| and λ⊥ have been shown to differentially detect axon and myelin abnormalities in several mouse models of central nervous system white matter pathology in our laboratory. These models include experimental autoimmune encephalomyelitis (EAE), (1) myelin basic protein mutant mice with dysmyelination and intact axons, (2) cuprizone-induced demyelination, and remyelination, with reversible axon injury (2, 3) and a model of retinal ischemia in which retinal ganglion cell death is followed by Wallerian degeneration of optic nerve, with axonal injury preceding demyelination. (4) Decreased λ|| correlates with acute axonal injury and increased λ⊥ indicates myelin damage. (4) More recently, we have translated this approach to human MR, investigating acute and chronic optic neuritis in adults with multiple sclerosis, brain lesions in adults with multiple sclerosis, and acute disseminated encephalomyelitis (ADEM) in children. We are also investigating the use of this technique to probe the underlying structural change of the cervical spinal cord in acute and chronic T2- hyperintense lesions in spinal stenosis, trauma, and transverse myelitis. In each of these demyelinating diseases, the discrimination between axonal and myelin injury which we can achieve has important prognostic and therapeutic implications. For those patients with myelin injury but intact axons, early, directed drug therapy has the potential to prevent progression to axonal loss and permanent disability.

Citation Download Citation

Tammie L. S. Benzinger, Anne H. Cross M.D., Junqian Xu, Robert Naismith, Shu-Wei Sun, and Sheng-Kwei Song "Directional diffusivity as a magnetic resonance (MR) biomarker in demyelinating disease", Proc. SPIE 6759, Smart Biomedical and Physiological Sensor Technology V, 67590O (5 October 2007); https://doi.org/10.1117/12.740133

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available